The drug repurposing service providers market is estimated to be worth USD 1.2 billion in 2030 Drug repurposing enables drug developers to optimize on past efforts and expenditure, thereby, offering a viable life cycle management strategy for marketed products and opportunities to re-evaluate failed / shelved drug development programs For more information please click on the following link: https://www.rootsanalysis.com/reports/drug-repurposing-service-provides.html